10 mg lyophilised · single compound
$85.00 CAD
Ipamorelin is a peptide that signals the body to release growth hormone, used widely in endocrine research. It is studied for being selective - prompting growth-hormone release with little effect on other hormones such as cortisol.
For laboratory and research use only - not for human consumption.
Checking the live COA archive for the newest lot documentation.
Use the verification archive to select a peptide name and review all published lot records alphabetically.
View previous lab resultsIpamorelin is a synthetic pentapeptide (five amino acids) that selectively activates the GH-secretagogue receptor (the ghrelin receptor), prompting release of the body’s own growth hormone.
Described in 1998 as the first selective GH secretagogue: in animals it released growth hormone as strongly as earlier compounds but, importantly, without meaningfully raising cortisol (a stress hormone) or prolactin. It is widely used as a reference tool in growth-hormone and ghrelin-receptor research.
Selective agonism (clean activation) of the ghrelin/GH-secretagogue receptor on pituitary cells, triggering GH release with a comparatively clean hormonal profile.
Ipamorelin is not an approved medicine; it is supplied as a research compound - not for human consumption.
A single vial containing 10 mg of Ipamorelin as a lyophilised powder.
